
ALK-Abello A/S
CSE:ALK B

ALK-Abello A/S?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
131.9
187.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does ALK-Abello A/S hold over its rivals?
What risks and challenges
does ALK-Abello A/S face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of ALK-Abello A/S.
Provide an overview of the primary business activities
of ALK-Abello A/S.
What unique competitive advantages
does ALK-Abello A/S hold over its rivals?
What risks and challenges
does ALK-Abello A/S face in the near future?
Summarize the latest earnings call
of ALK-Abello A/S.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for ALK-Abello A/S.
Provide P/S
for ALK-Abello A/S.
Provide P/E
for ALK-Abello A/S.
Provide P/OCF
for ALK-Abello A/S.
Provide P/FCFE
for ALK-Abello A/S.
Provide P/B
for ALK-Abello A/S.
Provide EV/S
for ALK-Abello A/S.
Provide EV/GP
for ALK-Abello A/S.
Provide EV/EBITDA
for ALK-Abello A/S.
Provide EV/EBIT
for ALK-Abello A/S.
Provide EV/OCF
for ALK-Abello A/S.
Provide EV/FCFF
for ALK-Abello A/S.
Provide EV/IC
for ALK-Abello A/S.
Show me price targets
for ALK-Abello A/S made by professional analysts.
What are the Revenue projections
for ALK-Abello A/S?
How accurate were the past Revenue estimates
for ALK-Abello A/S?
What are the Net Income projections
for ALK-Abello A/S?
How accurate were the past Net Income estimates
for ALK-Abello A/S?
What are the EPS projections
for ALK-Abello A/S?
How accurate were the past EPS estimates
for ALK-Abello A/S?
What are the EBIT projections
for ALK-Abello A/S?
How accurate were the past EBIT estimates
for ALK-Abello A/S?
Compare the revenue forecasts
for ALK-Abello A/S with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of ALK-Abello A/S and its key competitors using the latest financial data.
Compare historical revenue growth rates
of ALK-Abello A/S against its competitors.
Analyze the profit margins
(gross, operating, and net) of ALK-Abello A/S compared to its peers.
Compare the P/E ratios
of ALK-Abello A/S against its peers.
Discuss the investment returns and shareholder value creation
comparing ALK-Abello A/S with its peers.
Analyze the financial leverage
of ALK-Abello A/S compared to its main competitors.
Show all profitability ratios
for ALK-Abello A/S.
Provide ROE
for ALK-Abello A/S.
Provide ROA
for ALK-Abello A/S.
Provide ROIC
for ALK-Abello A/S.
Provide ROCE
for ALK-Abello A/S.
Provide Gross Margin
for ALK-Abello A/S.
Provide Operating Margin
for ALK-Abello A/S.
Provide Net Margin
for ALK-Abello A/S.
Provide FCF Margin
for ALK-Abello A/S.
Show all solvency ratios
for ALK-Abello A/S.
Provide D/E Ratio
for ALK-Abello A/S.
Provide D/A Ratio
for ALK-Abello A/S.
Provide Interest Coverage Ratio
for ALK-Abello A/S.
Provide Altman Z-Score Ratio
for ALK-Abello A/S.
Provide Quick Ratio
for ALK-Abello A/S.
Provide Current Ratio
for ALK-Abello A/S.
Provide Cash Ratio
for ALK-Abello A/S.
What is the historical Revenue growth
over the last 5 years for ALK-Abello A/S?
What is the historical Net Income growth
over the last 5 years for ALK-Abello A/S?
What is the current Free Cash Flow
of ALK-Abello A/S?
Discuss the annual earnings per share (EPS)
trend over the past five years for ALK-Abello A/S.
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
DK |
![]() |
ALK-Abello A/S
CSE:ALK B
|
41.1B DKK | 11.1 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
734.9B USD | 19.1 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 1 026 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
366.6B USD | 6.2 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK | 7.8 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
208.1B CHF | 5 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
188.4B CHF | 6.3 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
158.5B GBP | 57.6 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
199B USD | 4.5 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD | 108.6 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
137.5B USD | 3.8 |
|
DK |
![]() |
ALK-Abello A/S
CSE:ALK B
|
Average EV/GP:
114.2
11.1
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
19.1
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
1 026
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
6.2
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
7.8
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
5
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
6.3
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
57.6
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
4.5
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
108.6
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
3.8
|
|
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.